Literature DB >> 16177364

Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae.

Maha Jomaa1, Jose Yuste, James C Paton, Christopher Jones, Gordon Dougan, Jeremy S Brown.   

Abstract

PiaA and PiuA are the lipoprotein components of the Pia and Piu Streptococcus pneumoniae iron uptake ABC transporters and are required for full virulence in mouse models of infection. Active or passive vaccination with recombinant PiuA and PiaA protects mice against invasive S. pneumoniae disease. In this study we have analyzed the antibody responses and mechanism of protection induced by PiuA and PiaA in more detail. For both proteins, two booster vaccinations induced stronger antibody responses in mice than a single or no booster vaccinations, and 5 mug of protein induced similar levels of antibody responses as 20 mug. Immunoglobulin G (IgG) subclass-specific enzyme-linked immunosorbent assays demonstrated that the antibody response to PiuA and PiaA was predominantly IgG1, with induction of only low levels of IgG2a. Anti-PiaA and anti-PiuA polyclonal rabbit antibodies bound to the surface of live S. pneumoniae when assessed by flow cytometry but did not inhibit growth of S. pneumoniae in cation-depleted medium or bacterial susceptibility to the iron-dependent antibiotic streptonigrin. However, anti-PiaA and anti-PiuA did increase complement-independent and -dependent opsonophagocytosis of different serotypes of S. pneumoniae by the human neutrophil cell line HL60. Hence, vaccination with PiaA and PiuA protects against S. pneumoniae infection by inducing antibodies that promote bacterial opsonophagocytosis rather than inhibiting iron transport.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177364      PMCID: PMC1230898          DOI: 10.1128/IAI.73.10.6852-6859.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.

Authors:  Jeremy S Brown; Tracy Hussell; Sarah M Gilliland; David W Holden; James C Paton; Michael R Ehrenstein; Mark J Walport; Marina Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

2.  A solute binding protein of Streptococcus pneumoniae iron transport.

Authors:  Stanley S Tai; Chialin Yu; Janice K Lee
Journal:  FEMS Microbiol Lett       Date:  2003-03-28       Impact factor: 2.742

3.  Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.

Authors:  A D Ogunniyi; M C Woodrow; J T Poolman; J C Paton
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.

Authors:  J S Brown; A D Ogunniyi; M C Woodrow; D W Holden; J C Paton
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.

Authors:  E N Miyaji; W O Dias; M Gamberini; V C Gebara; R P Schenkman; J Wild; P Riedl; J Reimann; R Schirmbeck; L C Leite
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

6.  Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.

Authors:  Dennis O Gor; Xuedong Ding; David E Briles; Michael R Jacobs; Neil S Greenspan
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.

Authors:  Eliane N Miyaji; Waldely O Dias; Martha M Tanizaki; Luciana C C Leite
Journal:  FEMS Immunol Med Microbiol       Date:  2003-06-10

Review 8.  Iron acquisition by Gram-positive bacterial pathogens.

Authors:  Jeremy S Brown; David W Holden
Journal:  Microbes Infect       Date:  2002-09       Impact factor: 2.700

9.  Characterization of pit, a Streptococcus pneumoniae iron uptake ABC transporter.

Authors:  Jeremy S Brown; Sarah M Gilliland; Javier Ruiz-Albert; David W Holden
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 10.  Novel vaccine strategies with protein antigens of Streptococcus pneumoniae.

Authors:  Edwin Swiatlo; Daphne Ware
Journal:  FEMS Immunol Med Microbiol       Date:  2003-08-18
View more
  35 in total

1.  Impact of glutamine transporters on pneumococcal fitness under infection-related conditions.

Authors:  Tobias Härtel; Matthias Klein; Uwe Koedel; Manfred Rohde; Lothar Petruschka; Sven Hammerschmidt
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Identification of genes that contribute to the pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis.

Authors:  Abiodun D Ogunniyi; Layla K Mahdi; Claudia Trappetti; Nadine Verhoeven; Daphne Mermans; Mark B Van der Hoek; Charles D Plumptre; James C Paton
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 3.  Lipoproteins of bacterial pathogens.

Authors:  A Kovacs-Simon; R W Titball; S L Michell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

4.  The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.

Authors:  Jose Yuste; Suneeta Khandavilli; Naadir Ansari; Kairya Muttardi; Laura Ismail; C Hyams; Jeffrey Weiser; Timothy Mitchell; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

5.  Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.

Authors:  Suneeta Chimalapati; Jonathan Cohen; Emilie Camberlein; Claire Durmort; Helen Baxendale; Corné de Vogel; Alex van Belkum; Jeremy S Brown
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

6.  Immunization with polyamine transport protein PotD protects mice against systemic infection with Streptococcus pneumoniae.

Authors:  P Shah; E Swiatlo
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

Review 7.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Analysis of the protective capacity of three Streptococcus suis proteins induced under divalent-cation-limited conditions.

Authors:  Jesús Aranda; Maria Elena Garrido; Pilar Cortés; Montserrat Llagostera; Jordi Barbé
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

9.  Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.

Authors:  Jose Yuste; Ashwin Sen; Lennart Truedsson; Göran Jönsson; Liang-Seah Tay; Catherine Hyams; Helen E Baxendale; Fiona Goldblatt; Marina Botto; Jeremy S Brown
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

10.  Identification of conserved antigens for early serodiagnosis of relapsing fever Borrelia.

Authors:  Job E Lopez; Stephen F Porcella; Merry E Schrumpf; Sandra J Raffel; Carl H Hammer; Ming Zhao; Mary Ann Robinson; Tom G Schwan
Journal:  Microbiology (Reading)       Date:  2009-05-14       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.